|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM121409317 |
| 003 |
DE-627 |
| 005 |
20231222193037.0 |
| 007 |
tu |
| 008 |
231222s1996 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0405.xml
|
| 035 |
|
|
|a (DE-627)NLM121409317
|
| 035 |
|
|
|a (NLM)12346947
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Killick, S
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Don't be scared
|
| 264 |
|
1 |
|c 1996
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 01.05.1996
|
| 500 |
|
|
|a Date Revised 23.11.2016
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Behavior
|
| 650 |
|
4 |
|a Communication
|
| 650 |
|
4 |
|a Contraception
|
| 650 |
|
4 |
|a Contraceptive Agents
|
| 650 |
|
4 |
|a Contraceptive Agents, Female
|
| 650 |
|
4 |
|a Contraceptive Agents, Progestin
|
| 650 |
|
4 |
|a Contraceptive Methods
|
| 650 |
|
4 |
|a Desogestrel
|
| 650 |
|
4 |
|a Developed Countries
|
| 650 |
|
4 |
|a Diseases
|
| 650 |
|
4 |
|a Distributional Activities
|
| 650 |
|
4 |
|a Embolism
|
| 650 |
|
4 |
|a Emotions
|
| 650 |
|
4 |
|a Europe
|
| 650 |
|
4 |
|a Family Planning
|
| 650 |
|
4 |
|a Family Planning Program Evaluation
|
| 650 |
|
4 |
|a Family Planning Programs
|
| 650 |
|
4 |
|a Fear
|
| 650 |
|
4 |
|a Gestodene
|
| 650 |
|
4 |
|a Information Distribution
|
| 650 |
|
4 |
|a Logistics
|
| 650 |
|
4 |
|a Management
|
| 650 |
|
4 |
|a Mass Media
|
| 650 |
|
4 |
|a Northern Europe
|
| 650 |
|
4 |
|a Obstacles
|
| 650 |
|
4 |
|a Oral Contraceptives
|
| 650 |
|
4 |
|a Oral Contraceptives, Combined
|
| 650 |
|
4 |
|a Organization And Administration
|
| 650 |
|
4 |
|a Prescriptions--changes
|
| 650 |
|
4 |
|a Program Activities
|
| 650 |
|
4 |
|a Programs
|
| 650 |
|
4 |
|a Psychological Factors
|
| 650 |
|
4 |
|a Thromboembolism
|
| 650 |
|
4 |
|a United Kingdom
|
| 650 |
|
4 |
|a Vascular Diseases
|
| 650 |
|
7 |
|a Contraceptive Agents
|2 NLM
|
| 650 |
|
7 |
|a Contraceptive Agents, Female
|2 NLM
|
| 650 |
|
7 |
|a Contraceptives, Oral
|2 NLM
|
| 650 |
|
7 |
|a Contraceptives, Oral, Combined
|2 NLM
|
| 650 |
|
7 |
|a Desogestrel
|2 NLM
|
| 650 |
|
7 |
|a 81K9V7M3A3
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Audit Unit News
|d 1996
|g 1(1996), 4 vom: 18. Jan., Seite 1
|w (DE-627)NLM09825264X
|7 nnns
|
| 773 |
1 |
8 |
|g volume:1
|g year:1996
|g number:4
|g day:18
|g month:01
|g pages:1
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_289
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 1
|j 1996
|e 4
|b 18
|c 01
|h 1
|